{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:05:01Z","timestamp":1790665501259,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11060-022-04124-2","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:15:21Z","timestamp":1662452121000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Meningioma in patients exposed to progestin drugs: results from a real-life screening program"],"prefix":"10.1007","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7259-7876","authenticated-orcid":false,"given":"Thomas","family":"Samoyeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0200-4027","authenticated-orcid":false,"given":"Corentin","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9597-673X","authenticated-orcid":false,"given":"Alexandre","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-7405","authenticated-orcid":false,"given":"Laurence","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Dezamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1020-8142","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Plu-Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-9844","authenticated-orcid":false,"given":"Johan","family":"Pallud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-0862","authenticated-orcid":false,"given":"Catherine","family":"Oppenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0733-0104","authenticated-orcid":false,"given":"Joseph","family":"Benzakoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"4124_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G et al (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro-Oncol 20:1\u201386. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro-Oncol"},{"key":"4124_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307\u2013314. https:\/\/doi.org\/10.1007\/s11060-010-0386-3","journal-title":"J Neurooncol"},{"key":"4124_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neuchi.2014.05.006","volume":"64","author":"I Baldi","year":"2018","unstructured":"Baldi I, Engelhardt J, Bonnet C et al (2018) Epidemiology of meningiomas. Neurochirurgie 64:5\u201314. https:\/\/doi.org\/10.1016\/j.neuchi.2014.05.006","journal-title":"Neurochirurgie"},{"key":"4124_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3171\/jns.2006.105.2.163","volume":"105","author":"S Pravdenkova","year":"2006","unstructured":"Pravdenkova S, Husain M (2006) Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 105:163\u2013173. https:\/\/doi.org\/10.3171\/jns.2006.105.2.163","journal-title":"J Neurosurg"},{"key":"4124_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0022-4731(86)90320-1","volume":"25","author":"F Neumann","year":"1986","unstructured":"Neumann F (1986) Pharmacology of antiandrogens. J Steroid Biochem 25:885\u2013895. https:\/\/doi.org\/10.1016\/0022-4731(86)90320-1","journal-title":"J Steroid Biochem"},{"key":"4124_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","volume":"76","author":"AO Mueck","year":"2011","unstructured":"Mueck AO, Sitruk-Ware R (2011) Nomegestrol acetate, a novel progestogen for oral contraception. Steroids 76:531\u2013539. https:\/\/doi.org\/10.1016\/j.steroids.2011.02.002","journal-title":"Steroids"},{"key":"4124_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.contraception.2008.10.017","volume":"79","author":"R Druckmann","year":"2009","unstructured":"Druckmann R (2009) Profile of the progesterone derivative chlormadinone acetate\u2014pharmocodynamic properties and therapeutic applications. Contraception 79:272\u2013281. https:\/\/doi.org\/10.1016\/j.contraception.2008.10.017","journal-title":"Contraception"},{"key":"4124_CR8","first-page":"181","volume-title":"Hyperandrogenism in adolescent girls. Endocr Dev","author":"S Catteau-Jonard","year":"2012","unstructured":"Catteau-Jonard S, Richard-Proust C (2012) Hyperandrogenism in adolescent girls. Endocr Dev, pp 181\u2013193"},{"key":"4124_CR9","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMc071938","volume":"357","author":"R Gazzeri","year":"2007","unstructured":"Gazzeri R, Galarza M, Gazzeri G (2007) Growth of a meningioma in a transsexual patient after estrogen\u2013progestin therapy. N Engl J Med 357:2411\u20132412. https:\/\/doi.org\/10.1056\/NEJMc071938","journal-title":"N Engl J Med"},{"key":"4124_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2176\/nmc.48.227","volume":"48","author":"J Shimizu","year":"2008","unstructured":"Shimizu J, Matsumoto M, Yamazaki E, Yasue M (2008) Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration. Neurol Med Chir (Tokyo) 48:227\u2013230. https:\/\/doi.org\/10.2176\/nmc.48.227","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"4124_CR11","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3174\/ajnr.A1978","volume":"31","author":"AMG Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves AMG, Page P, Domigo V et al (2010) Abrupt regression of a meningioma after discontinuation of cyproterone treatment: Fig 1. Am J Neuroradiol 31:1504\u20131505. https:\/\/doi.org\/10.3174\/ajnr.A1978","journal-title":"Am J Neuroradiol"},{"key":"4124_CR12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","volume":"72","author":"M Gil","year":"2011","unstructured":"Gil M, Oliva B, Timoner J et al (2011) Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study: risk of meningioma among users of high doses of cyproterone acetate. Br J Clin Pharmacol 72:965\u2013968. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04031.x","journal-title":"Br J Clin Pharmacol"},{"key":"4124_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canep.2011.08.003","volume":"36","author":"L Cea-Soriano","year":"2012","unstructured":"Cea-Soriano L, Blenk T, Wallander M-A, Rodr\u00edguez LAG (2012) Hormonal therapies and meningioma: Is there a link? Cancer Epidemiol 36:198\u2013205. https:\/\/doi.org\/10.1016\/j.canep.2011.08.003","journal-title":"Cancer Epidemiol"},{"key":"4124_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/15532739.2012.725563","volume":"14","author":"EJ Knight","year":"2013","unstructured":"Knight EJ, McDonald MJ (2013) Recurrence and progression of meningioma in male-to-female transgender individuals during exogenous hormone use. Int J Transgenderism 14:18\u201323. https:\/\/doi.org\/10.1080\/15532739.2012.725563","journal-title":"Int J Transgenderism"},{"key":"4124_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.endonu.2012.07.004","volume":"60","author":"MT Bergoglio","year":"2013","unstructured":"Bergoglio MT, G\u00f3mez-Balaguer M, Almonacid Folch E et al (2013) Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual. Endocrinol Nutr 60:264\u2013267. https:\/\/doi.org\/10.1016\/j.endonu.2012.07.004","journal-title":"Endocrinol Nutr"},{"key":"4124_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15226\/2374-6858\/1\/2\/00109","volume":"1","author":"HB Razavi","year":"2014","unstructured":"Razavi HB (2014) Meningioma: the unusual growth in a transsexual patient after estrogen-progesterone therapy. SOJ Neurol 1:1\u20133. https:\/\/doi.org\/10.15226\/2374-6858\/1\/2\/00109","journal-title":"SOJ Neurol"},{"key":"4124_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ando.2015.07.276","volume":"76","author":"S Papadopoulou","year":"2015","unstructured":"Papadopoulou S, Chambre C, Baudry C et al (2015) Une complication rare de l\u2019ac\u00e9tate de cyprot\u00e9rone chez une patiente acrom\u00e9gale. Ann Endocrinol 76:388\u2013389. https:\/\/doi.org\/10.1016\/j.ando.2015.07.276","journal-title":"Ann Endocrinol"},{"key":"4124_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2324-8599.1000183","volume":"5","author":"A Supartoto","year":"2016","unstructured":"Supartoto A, Mahayana IT, Christine RN (2016) Exposure to exogenous female sex hormones is associated with increased risk of orbito-cranial meningioma in females: a case-control study. Int J Ophthalmic Pathol 5:1\u20136. https:\/\/doi.org\/10.4172\/2324-8599.1000183","journal-title":"Int J Ophthalmic Pathol"},{"key":"4124_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/jovr.jovr_21_17","volume":"13","author":"A Bernat","year":"2018","unstructured":"Bernat A, Bonnin S, Labidi M et al (2018) Regression of giant olfactory groove meningioma and complete visual acuity recovery after discontinuation of cyproterone acetate. J Ophthalmic Vis Res 13:355. https:\/\/doi.org\/10.4103\/jovr.jovr_21_17","journal-title":"J Ophthalmic Vis Res"},{"key":"4124_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/15532739.2017.1413615","volume":"19","author":"M Boer","year":"2018","unstructured":"Boer M, Moernaut L, Van Calenbergh F et al (2018) Variation of meningioma in response to cyproterone acetate in a trans woman. Int J Transgenderism 19:92\u201394. https:\/\/doi.org\/10.1080\/15532739.2017.1413615","journal-title":"Int J Transgenderism"},{"key":"4124_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/09513590.2017.1395839","volume":"34","author":"I Mancini","year":"2018","unstructured":"Mancini I, Rotilio A, Coati I et al (2018) Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. Gynecol Endocrinol 34:456\u2013459. https:\/\/doi.org\/10.1080\/09513590.2017.1395839","journal-title":"Gynecol Endocrinol"},{"key":"4124_CR22","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awy108","volume":"141","author":"NM Nota","year":"2018","unstructured":"Nota NM, Wiepjes CM, de Blok CJM et al (2018) The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain 141:2047\u20132054. https:\/\/doi.org\/10.1093\/brain\/awy108","journal-title":"Brain"},{"key":"4124_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuchi.2019.12.013","volume":"66","author":"A Roux","year":"2020","unstructured":"Roux A, Tauziede-Espariat A, Zanello M et al (2020) Symptomatic progestin-associated atypical grade II meningioma. A first case report. Neurochirurgie 66:174\u2013178. https:\/\/doi.org\/10.1016\/j.neuchi.2019.12.013","journal-title":"Neurochirurgie"},{"key":"4124_CR24","first-page":"158","volume-title":"Does cyproterone acetate promote multiple meningiomas? Endocr Abstr","author":"S Froelich","year":"2008","unstructured":"Froelich S, Dali-Youcef N, Boyer P, et al (2008) Does cyproterone acetate promote multiple meningiomas? Endocr Abstr 158\u2013161"},{"key":"4124_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.neuchi.2015.05.002","volume":"61","author":"C Botella","year":"2015","unstructured":"Botella C, Coll G, Lemaire J-J, Irthum B (2015) M\u00e9ningiomes intracr\u00e2niens et utilisation prolong\u00e9e d\u2019ac\u00e9tate de cyprot\u00e9rone \u00e0 dose conventionnelle chez la femme\u202f: \u00e0 propos de deux cas de r\u00e9gression tumorale apr\u00e8s arr\u00eat du traitement. Neurochirurgie 61:339\u2013342. https:\/\/doi.org\/10.1016\/j.neuchi.2015.05.002","journal-title":"Neurochirurgie"},{"key":"4124_CR26","doi-asserted-by":"publisher","first-page":"814.e7","DOI":"10.1016\/j.wneu.2017.03.013","volume":"101","author":"M Kalamarides","year":"2017","unstructured":"Kalamarides M, Peyre M (2017) Dramatic shrinkage with reduced vascularization of large meningiomas after cessation of progestin treatment. World Neurosurg 101:814.e7-814.e10. https:\/\/doi.org\/10.1016\/j.wneu.2017.03.013","journal-title":"World Neurosurg"},{"key":"4124_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00701-018-03782-4","volume":"161","author":"P-O Champagne","year":"2019","unstructured":"Champagne P-O, Passeri T, Froelich S (2019) Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report. Acta Neurochir (Wien) 161:589\u2013592. https:\/\/doi.org\/10.1007\/s00701-018-03782-4","journal-title":"Acta Neurochir (Wien)"},{"key":"4124_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00701-019-03848-x","volume":"161","author":"T Passeri","year":"2019","unstructured":"Passeri T, Champagne P-O, Bernat A-L et al (2019) Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir (Wien) 161:761\u2013765. https:\/\/doi.org\/10.1007\/s00701-019-03848-x","journal-title":"Acta Neurochir (Wien)"},{"key":"4124_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11060-021-03696-9","volume":"152","author":"H Malaize","year":"2021","unstructured":"Malaize H, Samoyeau T, Zanello M et al (2021) Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience. J Neurooncol 152:279\u2013288. https:\/\/doi.org\/10.1007\/s11060-021-03696-9","journal-title":"J Neurooncol"},{"key":"4124_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.n37","volume":"37","author":"A Weill","year":"2021","unstructured":"Weill A, Nguyen P, Labidi M et al (2021) Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. Br Med J 37:1\u201313. https:\/\/doi.org\/10.1136\/bmj.n37","journal-title":"Br Med J"},{"key":"4124_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15423","author":"L Hoisnard","year":"2022","unstructured":"Hoisnard L, Laanani M, Passeri T et al (2022) Risk of intracranial meningioma with three potent progestogens: a population-based case\u2013control study. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.15423","journal-title":"Eur J Neurol"},{"key":"4124_CR32","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/s41598-022-05773-z","volume":"12","author":"KS Lee","year":"2022","unstructured":"Lee KS, Zhang JJY, Kirollos R et al (2022) A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas. Sci Rep 12:1942. https:\/\/doi.org\/10.1038\/s41598-022-05773-z","journal-title":"Sci Rep"},{"key":"4124_CR33","unstructured":"ANSM (2018) CSST \u00ab\u202fAcetate de cyproterone et risque de meningiomes\u202f\u00bb. In: https:\/\/ansm.sante.fr\/. https:\/\/ansm.sante.fr\/actualites\/androcur-et-generiques-acetate-de-cyproterone-50-mg-et-100-mg-et-risque-de-meningiome-lansm-publie-des-recommandations-pour-la-prise-en-charge-des-patients"},{"key":"4124_CR34","unstructured":"ANSM (2020) CSST \u00ab\u202fMacroprogestatifs et risque de m\u00e9ningiomes\u202f\u00bb. In: https:\/\/ansm.sante.fr\/. https:\/\/ansm.sante.fr\/evenements\/comite-macroprogestatifs-et-risque-de-meningiome"},{"key":"4124_CR35","doi-asserted-by":"publisher","first-page":"i44","DOI":"10.1093\/neuonc\/noy143","volume":"21","author":"RY Huang","year":"2019","unstructured":"Huang RY, Bi WL, Griffith B et al (2019) Imaging and diagnostic advances for intracranial meningiomas. Neuro-Oncol 21:i44\u2013i61. https:\/\/doi.org\/10.1093\/neuonc\/noy143","journal-title":"Neuro-Oncol"},{"key":"4124_CR36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3171\/2008.8.JNS08481","volume":"110","author":"T Hashiba","year":"2009","unstructured":"Hashiba T, Suzuki T, Kato A (2009) Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas. J Neurosurg 110:675\u2013684. https:\/\/doi.org\/10.3171\/2008.8.JNS08481","journal-title":"J Neurosurg"},{"key":"4124_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0090-3019(87)90005-X","volume":"27","author":"S Nakasu","year":"1987","unstructured":"Nakasu S, Hirano A, Shimura T, Llena JF (1987) Incidental meningiomas in autopsy study. Surg Neurol 27:319\u2013322. https:\/\/doi.org\/10.1016\/0090-3019(87)90005-X","journal-title":"Surg Neurol"},{"key":"4124_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0151080","volume":"11","author":"AK H\u00e5berg","year":"2016","unstructured":"H\u00e5berg AK, Hammer TA, Kvistad KA et al (2016) Incidental intracranial findings and their clinical impact; the HUNT MRI study in a general population of 1006 participants between 50\u201366 years. PLoS ONE 11:1\u201320. https:\/\/doi.org\/10.1371\/journal.pone.0151080","journal-title":"PLoS ONE"},{"key":"4124_CR39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070972","author":"MW Vernooij","year":"2007","unstructured":"Vernooij MW (2007) Incidental findings on brain MRI in the general population. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa070972","journal-title":"N Engl J Med"},{"key":"4124_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF02100156","volume":"21","author":"HC Nahser","year":"1981","unstructured":"Nahser HC, Grote W, L\u00f6hr E, Gerhard L (1981) Multiple meningiomas. Clin Comput Tomogr Observ Neuroradiol 21:259\u2013263. https:\/\/doi.org\/10.1007\/BF02100156","journal-title":"Clin Comput Tomogr Observ Neuroradiol"},{"key":"4124_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1227\/00006123-198108000-00004","volume":"9","author":"JO Lusins","year":"1981","unstructured":"Lusins JO, Nakagawa H (1981) Multiple Meningiomas evaluated by computed tomography. Neurosurgery 9:137\u2013141. https:\/\/doi.org\/10.1227\/00006123-198108000-00004","journal-title":"Neurosurgery"},{"key":"4124_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/neuros\/nyab175","volume":"89","author":"EHJ Voormolen","year":"2021","unstructured":"Voormolen EHJ, Champagne PO, Roca E et al (2021) Intracranial Meningiomas decrease in volume on magnetic resonance imaging after discontinuing progestin. Neurosurgery 89:308\u2013314. https:\/\/doi.org\/10.1093\/neuros\/nyab175","journal-title":"Neurosurgery"},{"key":"4124_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/annonc\/mdx763","volume":"29","author":"M Peyre","year":"2018","unstructured":"Peyre M, Gaillard S, de Marcellus C et al (2018) Progestin-associated shift of meningioma mutational landscape. Ann Oncol 29:681\u2013686. https:\/\/doi.org\/10.1093\/annonc\/mdx763","journal-title":"Ann Oncol"},{"key":"4124_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11060-020-03672-9","volume":"151","author":"C Champeaux-Depond","year":"2021","unstructured":"Champeaux-Depond C, Weller J, Froelich S, Sartor A (2021) Cyproterone acetate and meningioma: a nationwide-wide population based study. J Neurooncol 151:331\u2013338. https:\/\/doi.org\/10.1007\/s11060-020-03672-9","journal-title":"J Neurooncol"},{"key":"4124_CR45","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/nop\/npz011","volume":"6","author":"M Behbahani","year":"2019","unstructured":"Behbahani M, Skeie GO, Eide GE et al (2019) A prospective study of the natural history of incidental meningioma\u2014hold your horses! Neuro-Oncol Pract 6:438\u2013450. https:\/\/doi.org\/10.1093\/nop\/npz011","journal-title":"Neuro-Oncol Pract"},{"key":"4124_CR46","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1148\/radiol.2018181151","volume":"289","author":"RJ McDonald","year":"2018","unstructured":"McDonald RJ, Levine D, Weinreb J et al (2018) Gadolinium retention: a research roadmap from the 2018 NIH\/ACR\/RSNA workshop on gadolinium chelates. Radiology 289:517\u2013534. https:\/\/doi.org\/10.1148\/radiol.2018181151","journal-title":"Radiology"},{"key":"4124_CR47","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3174\/ajnr.A7170","volume":"42","author":"J Boto","year":"2021","unstructured":"Boto J, Guatta R, Fitsiori A et al (2021) Is contrast medium really needed for follow-up MRI of untreated intracranial Meningiomas? Am J Neuroradiol 42:1421\u20131428. https:\/\/doi.org\/10.3174\/ajnr.A7170","journal-title":"Am J Neuroradiol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-022-04124-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T09:07:35Z","timestamp":1667207255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-022-04124-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["4124"],"URL":"https:\/\/doi.org\/10.1007\/s11060-022-04124-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"In accordance with French legislation, formal approval by an Ethics Committee was not required and commitment to compliance rules was fulfilled in respect to the General Data Protection Regulation (Reference TDCP-GEST-16, University of Paris).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}